HopeStage
Back to all studies
CompletedNCT03841292

Brain Stimulation Added to Varenicline for Quitting Tobacco

About this titleRead the official source — NCT03841292
Medication studyAges 19–65CanadaAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 19 years to 65 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 1, 2018
Recruitment status
Completed
Enrollment listed in the registry
41
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Device, Drug
Locations
Canada
Age range
From 19 Years to 65 Years
Official registry ID
NCT03841292
Official title
Show the full official title

Using Non-invasive Brain Stimulation (tDCS) to Improve the Effectiveness of Varenicline for Treating Tobacco Dependence: a Randomized Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Varenicline.

Who was this study for?

Listed age limits: 19 years to 65 years.

Want to explore more studies?

Explore studies